Pyxis Oncology, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINEPRE 14APyxis Oncology, Inc.PYXSOct 9

   Pyxis Oncology to hold virtual meeting on Nov 13

   • Special Meeting on Nov 13, 2026
   • Approval of increasing common stock shares from 190M to 380M
   • Virtual meeting format with online voting
2. ROUTINESCHEDULE 13G/APyxis Oncology, Inc.PYXSOct 9

   Pyxis Oncology, Inc. (PYXS) reports major stake

   • GordonMD Global Investments LP owns 16.4% of PYXS
   • GordonMD Long Biased Master Fund LP owns 16.4% of PYXS
   • Includes 4,900,039 shares from warrants

   GordonMD Global Investments LP, filed by

3. ROUTINE4/APyxis Oncology, Inc.PYXSOct 9

   GordonMD Global Investments LP filed Form 4/A

   • Filed on 2026-10-09
   • Corrected warrant count from previous filing
   • 7,172,000 warrants reported

   GordonMD Global Investments LP, reporting · GordonMD Long Biased GP LLC, reporting · +2 more

4. ROUTINESCHEDULE 13GPyxis Oncology, Inc.PYXSOct 5

   Pyxis Oncology, Inc. shares held by Coastlands Capital LP

   • Coastlands Capital LP holds 6,448,907 shares
   • 5.42% of the company's shares
   • Filing date: 2026-10-05

   Coastlands Capital LP

5. ROUTINESCHEDULE 13G/APyxis Oncology, Inc.PYXSOct 2

   Pyxis Oncology, Inc. 17.5% stake held by GordonMD

   • GordonMD Global Investments LP owns 17.5% of Pyxis Oncology
   • Includes 27,988,714 shares of common stock
   • Warrants include 12,446,805 shares but subject to 17.5% blocker

   GordonMD Global Investments LP

6. ROUTINE4Pyxis Oncology, Inc.PYXSOct 2

   Pyxis Oncology, Inc. (PYXS) reports major ownership changes.

   • GordonMD Global Investments LP acquired 5,517,000 shares on 10/01/2026.
   • GordonMD Long Biased Master Fund LP holds 7,546,766 warrants with an exercise price of $3.5.

   GordonMD Global Investments LP · GordonMD Long Biased GP LLC · +2 more

7. ROUTINE8-KPyxis Oncology, Inc.PYXSOct 1

   Current report

8. ROUTINE424B5Pyxis Oncology, Inc.PYXSOct 1

   Securities offering

9. ROUTINE424B5Pyxis Oncology, Inc.PYXSSep 29

   2 structured-note prospectuses

   Securities offering

   Show all 2

   • 424B5Securities offeringSep 29
   • 424B5Securities offeringSep 29
10. ROUTINE8-KPyxis Oncology, Inc.PYXSSep 9

    Current report

11. ROUTINE4Pyxis Oncology, Inc.PYXSSep 8

    Thomas Civik, insider filing for PYXS

    Thomas Civik, reporting

12. ROUTINE8-KPyxis Oncology, Inc.PYXSSep 8

    Current report

13. ROUTINE424B2Pyxis Oncology, Inc.PYXSAug 28

    Securities offering

14. ROUTINEEFFECTPyxis Oncology, Inc.PYXSAug 28

    Registration declared effective

15. ROUTINE4Pyxis Oncology, Inc.PYXSAug 20

    Jakob Dupont, insider filing for PYXS

    Jakob Dupont, reporting

16. ROUTINES-3Pyxis Oncology, Inc.PYXSAug 20

    Securities offering

17. ROUTINE4Pyxis Oncology, Inc.PYXSAug 14

    Thomas Civik, insider filing for PYXS

    Thomas Civik, reporting

18. NOTABLE10-QPyxis Oncology, Inc.PYXSAug 13

    Quarterly report

19. ROUTINE8-KPyxis Oncology, Inc.PYXSAug 13

    Current report

20. ROUTINE3Pyxis Oncology, Inc.PYXSJul 10

    GordonMD Global Investments LP, new insider at PYXS

    GordonMD Global Investments LP, reporting · GordonMD Long Biased GP LLC, reporting · +2 more

21. ROUTINESCHEDULE 13GPyxis Oncology, Inc.PYXSJul 10

    Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND L P, filed by

22. ROUTINE4Pyxis Oncology, Inc.PYXSJul 2

    Jakob Dupont, insider filing for PYXS

    Jakob Dupont, reporting

23. ROUTINE8-KPyxis Oncology, Inc.PYXSJul 2

    Current report

24. ROUTINESCHEDULE 13G/APyxis Oncology, Inc.PYXSJul 2

    Ownership stake disclosure by GordonMD Global Investments LP (amended)

    GordonMD Global Investments LP, filed by

25. ROUTINE144Pyxis Oncology, Inc.PYXSJun 30

    Jakob Dupont, planned sale of PYXS shares

    Jakob Dupont, reporting

26. ROUTINE8-KPyxis Oncology, Inc.PYXSJun 15

    Current report

27. NOTABLE10-QPyxis Oncology, Inc.PYXSMay 14

    Quarterly report

28. ROUTINE8-KPyxis Oncology, Inc.PYXSMay 14

    Current report

29. ROUTINEARSPyxis Oncology, Inc.PYXSApr 30

    Annual report to shareholders

30. ROUTINEDEFA14APyxis Oncology, Inc.PYXSApr 30

    Additional proxy materials

31. ROUTINEDEF 14APyxis Oncology, Inc.PYXSApr 30

    Proxy statement

32. ROUTINE8-K/APyxis Oncology, Inc.PYXSApr 30

    Current report (amended)

33. ROUTINE4Pyxis Oncology, Inc.PYXSMar 25

    9 insider filings

    Jakob Dupont, insider filing for PYXS

    Show all 9

    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25
    • 4Insider filing for PYXSMar 25

    Jakob Dupont, reporting

34. ROUTINES-8Pyxis Oncology, Inc.PYXSMar 23

    Employee stock plan registration

35. NOTABLE10-KPyxis Oncology, Inc.PYXSMar 23

    Annual report

36. ROUTINE8-KPyxis Oncology, Inc.PYXSMar 23

    Current report

37. ROUTINESCHEDULE 13G/APyxis Oncology, Inc.PYXSFeb 9

    Ownership stake disclosure by Laurion Capital Management LP (amended)

    Laurion Capital Management LP, filed by

38. ROUTINE8-KPyxis Oncology, Inc.PYXSFeb 6

    Current report

39. ROUTINE4Pyxis Oncology, Inc.PYXSFeb 5

    Thomas Civik, insider filing for PYXS

    Thomas Civik, reporting

40. ROUTINE8-KPyxis Oncology, Inc.PYXSDec 18, 2025

    Current report

41. ROUTINEEFFECTPyxis Oncology, Inc.PYXSDec 10, 2025

    Registration declared effective

Older filings on EDGAR